semaglutide lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs semaglutide gastrointestinal obstruction lawsuit in

doi: 10.1038/s41467-022-31963-4 164 SunJSongXWangCRuanQ

It is recommended for chronic inflammation, gut health and digestive issues, IBS and leaky gut support protocols, skin conditions such as acne, eczema or irritation, immune system imbalance, post illness recovery and general wellness and inflammation control

CHICAGO (February 2, 2026) With over 31 million people currently using GLP-1 drugs like Ozempic and Mounjaro, the conversation has shifted from weight loss success stories to serious legal questions

Whether it ultimately becomes a major player alongside Retatrutide remains to be seen, but one thing is clear: The era of multi-agonist metabolic peptides and triple-hormone incretin science is just getting started

Tests were carried out as described by the manufacturers instruction